Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

SELL
$12.81 - $16.38 $5,418 - $6,928
-423 Reduced 88.87%
53 $1,000
Q2 2022

Aug 01, 2022

SELL
$23.57 - $34.41 $1,249 - $1,823
-53 Reduced 10.02%
476 $12,000
Q1 2022

Apr 22, 2022

BUY
$28.95 - $34.84 $1,273 - $1,532
44 Added 9.07%
529 $18,000
Q4 2021

Jan 28, 2022

SELL
$29.82 - $36.05 $2,147 - $2,595
-72 Reduced 12.93%
485 $16,000
Q3 2021

Oct 22, 2021

SELL
$34.97 - $41.89 $34 - $41
-1 Reduced 0.18%
557 $19,000
Q2 2021

Jul 26, 2021

SELL
$36.7 - $42.13 $6,532 - $7,499
-178 Reduced 24.18%
558 $23,000
Q1 2021

Apr 22, 2021

BUY
$33.93 - $43.32 $7,328 - $9,357
216 Added 41.54%
736 $27,000
Q4 2020

Jan 27, 2021

SELL
$38.1 - $43.54 $9,791 - $11,189
-257 Reduced 33.08%
520 $22,000
Q3 2020

Oct 23, 2020

SELL
$41.37 - $46.55 $14,065 - $15,826
-340 Reduced 30.44%
777 $33,000
Q2 2020

Jul 24, 2020

BUY
$32.27 - $43.97 $34,335 - $46,784
1,064 Added 2007.55%
1,117 $48,000
Q1 2020

Apr 22, 2020

BUY
$29.21 - $42.02 $1,548 - $2,227
53 New
53 $1,000

Others Institutions Holding FMS

About Fresenius Medical Care AG & Co. KGaA


  • Ticker FMS
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 586,827,008
  • Market Cap $13B
  • Description
  • Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical moni...
More about FMS
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.